GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 14,000 Shares

January 24, 2013 | About:
insider

insider

56 followers
CEO of Biomarin Pharmaceutical, Inc. (BMRN) Jean Jacques Bienaime sells 14,000 shares of BMRN on 01/23/2013 at an average price of $55.06 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $6.75 billion; its shares were traded at around $54.53 with and P/S ratio of 13.5.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.


CEO Recent Trades:



  • CEO Jean Jacques Bienaime sold 14,000 shares of BMRN stock on 01/23/2013 at the average price of 55.06. Jean Jacques Bienaime owns at least 153,691 shares after this. The price of the stock has decreased by 0.96% since.
  • CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 01/18/2013 at the average price of 54. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 0.98% since.
  • CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 01/04/2013 at the average price of 52.24. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 4.38% since.
  • CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/31/2012 at the average price of 48.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 12.16% since.
  • CEO Jean Jacques Bienaime sold 17,000 shares of BMRN stock on 12/27/2012 at the average price of 48.37. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 12.74% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.




Directors and Officers Recent Trades:



  • SVP, Chief Commercial Of Jeffrey Robert Ajer sold 3,000 shares of BMRN stock on 01/22/2013 at the average price of 55. Jeffrey Robert Ajer owns at least 10,570 shares after this. The price of the stock has decreased by 0.85% since.
  • VP, Human Resources Mark Wood sold 46,749 shares of BMRN stock on 01/22/2013 at the average price of 54.99. Mark Wood owns at least 25,646 shares after this. The price of the stock has decreased by 0.84% since.
  • EVP, Technical Operations Robert Baffi sold 19,575 shares of BMRN stock on 01/22/2013 at the average price of 55. Robert Baffi owns at least 100,413 shares after this. The price of the stock has decreased by 0.85% since.
  • EVP, Technical Operations Robert Baffi sold 20,000 shares of BMRN stock on 01/03/2013 at the average price of 53. Robert Baffi owns at least 100,413 shares after this. The price of the stock has increased by 2.89% since.
  • Director Richard A Meier sold 10,000 shares of BMRN stock on 01/02/2013 at the average price of 51.25. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 6.4% since.


For the complete insider trading history of BMRN, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide